Article¦¢Open Access¦¢Published: 23 July 2021

Development of a quantitative prediction algorithm for target organ-specific similarity of human pluripotent stem cell-derived organoids and cells

Mi-Ok Lee, Su-gi Lee, Cho-Rok Jung, Ye Seul Son, Jae-Woon Ryu, Kwang Bo Jung, Jun-Ho Ahn, Jung-Hwa Oh, Hyang-Ae Lee, Jung Hwa Lim, Janghwan Kim, Insu Jang, Jinhyuk Choi, Jaeeun Jung, Kunhyang Park, Byungwook Lee, Dae-Soo Kim, Mi-Young Son & Hyun-Soo Cho

Nature Communications volume 12, Article number: 4492 (2021)

 

Abstract


Human pluripotent stem cell (hPSC)-derived organoids and cells have similar characteristics to human organs and tissues. Thus, in vitro human organoids and cells serve as a superior alternative to conventional cell lines and animal models in drug development and regenerative medicine. For a simple and reproducible analysis of the quality of organoids and cells to compensate for the shortcomings of existing experimental validation studies, a quantitative evaluation method should be developed. Here, using the GTEx database, we construct a quantitative calculation system to assess similarity to the human organs. To evaluate our system, we generate hPSC-derived organoids and cells, and detected organ similarity. To facilitate the access of our system by researchers, we develop a web-based user interface presenting similarity to the appropriate organs as percentages. Thus, this program could provide valuable information for the generation of high-quality organoids and cells and a strategy to guide proper lineage-oriented differentiation.

 

³í¹® º¸·¯ °¡±â

 

 

 


¼º°øÀûÀÎ Organoid CultureÀÇ Ã¹°ÉÀ½, ÁÁÀº Recombinant ProteinÀ» ¼±ÅÃÇÏ´Â °Í!

 

¿Ö! R&D Systems ProteinÀ» »ç¿ëÇØ¾ß ÇÒ±î¿ä?

 

1. More Active than Competitor: °æÀï»ç ´ëºñ ³ôÀº activity¸¦ º¸ÀÔ´Ï´Ù!

Comparison of the bioactivity of R&D Systems Recombinant Human Noggin and a leading competitor¡¯s Noggin indicates that the R&D Systems protein displays 30-fold higher activity.

Comparison of the bioactivity of R&D Systems Recombinant Human R-Spondin 1 and a leading competitor¡¯s R-Spondin 1 shows that the R&D Systems protein displays 7-fold higher activity.

Comparison of the bioactivity of R&D Systems Recombinant Human R-Spondin 1 and a leading competitor¡¯s R-Spondin 1 shows that the R&D Systems protein displays 7-fold higher activity.

Recombinant Human Noggin (Catalog # 6057-NG; orange line) and competitor (Blue line)

Recombinant Human R-Spondin 1 (Catalog # 4645-RS; blue line) and competitor (purple line)

Recombinant Human Wnt-3a (Catalog # 5036-WN; orange line) and competitor (blue line)

 

2. Lot-to-Lot Consistency

Comparison of the bioactivity of three different lots of R&D Systems Recombinant Human R-Spondin 1 demonstrates lot-to-lot consistency in the protein produced from three different manufacturing runs.

Comparison of the bioactivity of three different lots of R&D Systems Recombinant Human R-Spondin 1 demonstrates lot-to-lot consistency in the protein produced from three different manufacturing runs.

Recombinant Human R-Spondin 1

(Catalog # 4645-RS)

Recombinant Human Wnt-3a

(Catalog # 5036-WN)

 

Organoid protein list

Activin A

BMP-2

BMP-4

BMP-7

EGF

FGF-basic

FGF-7

FGF-9

FGF-10

FGF-19

HGF

Jagged-1

Noggin

R-Spondin 1

R-Spondin 3

Wnt-3a

Wnt-10b

 

 

»çÀÌÆ®¸í :(ÁÖ)¿õºñ¸ÞµðÅØ / »óÈ£:(ÁÖ)¿õºñ¸ÞµðÅØ
ÀüÈ­: 02-881-5432 / FAX: 02-881-5454
¼­¿ïƯº°½Ã ¼ÛÆı¸ ¼ÛÆÄ´ë·Î201µ¿ Å׶óŸ¿öAµ¿ 1113È£ (¹®Á¤µ¿642¹øÁö)
Copyright¨ÏAll Rights Reserved Any questions to woongbee@woongbee.com